# Alterity Therapeutics Ltd: Form 20-F for the period ended Jun 30, 2025

- Company: [Alterity Therapeutics Ltd](/companies/athe.md) (CIK 1131343)
- Form: 20-F
- Filed: 2025-08-29
- Accepted by EDGAR: Aug 28, 2025, 21:47 ET
- Period: 2025-06-30
- Accession: 0001213900-25-082027
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1131343/000121390025082027/ea0254438-20f_alterity.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1131343/000121390025082027/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Income tax | 12 months, 2024-07-01 to 2025-06-30 | AUD 68.1k | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2024-07-01 to 2025-06-30 | −AUD 12.1m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months, 2024-07-01 to 2025-06-30 | −AUD 0.19 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2024-07-01 to 2025-06-30 | −AUD 0.19 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2024-07-01 to 2025-06-30 | −AUD 11.5m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Cash and equivalents | at 2025-06-30 | AUD 33.2m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2025-06-30 | AUD 45.9m | ifrs-full:CurrentAssets |
| Total assets | at 2025-06-30 | AUD 46.0m | ifrs-full:Assets |
| Current liabilities | at 2025-06-30 | AUD 3.5m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2025-06-30 | AUD 3.6m | ifrs-full:Liabilities |
| Shareholders' equity | at 2025-06-30 | −AUD 225.9m | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | at 2025-06-30 | 9,127,370,686 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1131343/000121390025082027/ea0254438-20f_alterity.htm

Filed Aug 29, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-082027. Last ingested by Listed: Oct 30, 2026, 06:15 ET. No prices; not investment advice.